Symbols / NTRB $3.63 +0.83% Nutriband Inc.
NTRB Chart
About
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 44.19M |
| Enterprise Value | 39.08M | Income | -34.59M | Sales | 2.28M |
| Book/sh | 0.62 | Cash/sh | 0.44 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | -15.78 | PEG | — |
| P/S | 19.40 | P/B | 5.85 | P/C | — |
| EV/EBITDA | -4.33 | EV/Sales | 17.15 | Quick Ratio | 7.07 |
| Current Ratio | 7.53 | Debt/Eq | 3.42 | LT Debt/Eq | — |
| EPS (ttm) | -3.05 | EPS next Y | -0.23 | EPS Growth | — |
| Revenue Growth | -46.40% | Earnings | 2025-12-11 06:00 | ROA | -55.22% |
| ROE | -136.08% | ROIC | — | Gross Margin | 33.50% |
| Oper. Margin | -11.21% | Profit Margin | 0.00% | Shs Outstand | 12.17M |
| Shs Float | 4.91M | Short Float | 4.04% | Short Ratio | 16.18 |
| Short Interest | — | 52W High | 11.68 | 52W Low | 3.42 |
| Beta | 1.93 | Avg Volume | 13.95K | Volume | 9.62K |
| Target Price | $15.00 | Recom | None | Prev Close | $3.60 |
| Price | $3.63 | Change | 0.83% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$15.00
Mean price target
2. Current target
$3.63
Latest analyst target
3. DCF / Fair value
$-3.83
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.63
Low
$15.00
High
$15.00
Mean
$15.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-01-22 | init | Noble Capital Markets | — → Outperform | $13 |
| 2022-07-26 | main | Small Cap Consumer Research | — → Buy | $21 |
- Nutriband seeks FDA review for fentanyl patch designed to deter abuse - Stock Titan Mon, 30 Mar 2026 20
- Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates - MSN Wed, 01 Apr 2026 18
- NTRB Should I Buy - Intellectia AI Fri, 03 Apr 2026 07
- The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable - finance.yahoo.com hu, 29 Jan 2026 08
- Nutriband (NASDAQ:NTRB) shareholders are up 27% this past week, but still in the red over the last five years - simplywall.st ue, 30 Dec 2025 08
- Nutriband (NASDAQ: NTRB) Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch - The Globe and Mail Wed, 01 Apr 2026 15
- Nutriband Inc. CEO Shares 2025 Achievements and 2026 Outlook in Letter to Shareholders | NTRB Stock News - Quiver Quantitative Wed, 31 Dec 2025 08
- Nutriband stock soars on sale of Pocono Pharmaceutical stake - Investing.com Mon, 29 Dec 2025 08
- Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch - chartmill.com Mon, 30 Mar 2026 20
- What’s Driving Nutriband Shares Higher Today? - Stocktwits Mon, 29 Dec 2025 08
- NTRB Technical Analysis & Stock Price Forecast - Intellectia AI Wed, 01 Apr 2026 09
- Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval - finance.yahoo.com Wed, 02 Jul 2025 07
- Nutriband shareholders approve director slate and increase in preferred stock - Investing.com ue, 03 Feb 2026 08
- Nutriband shareholders approve proposals and expand board leadership - The Globe and Mail Wed, 04 Feb 2026 08
- NutriBand authorizes new Series A preferred stock and announces dividend - Investing.com Wed, 16 Jul 2025 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
2.14
+2.60%
|
2.09
+0.27%
|
2.08
+46.23%
|
1.42
|
| Operating Revenue |
|
2.14
+2.60%
|
2.09
+0.27%
|
2.08
+46.23%
|
1.42
|
| Cost Of Revenue |
|
1.40
+14.14%
|
1.22
-7.97%
|
1.33
+44.82%
|
0.92
|
| Reconciled Cost Of Revenue |
|
1.40
+14.14%
|
1.22
-7.97%
|
1.33
+44.82%
|
0.92
|
| Gross Profit |
|
0.74
-13.78%
|
0.86
+14.88%
|
0.75
+48.80%
|
0.50
|
| Operating Expense |
|
7.43
+29.63%
|
5.73
+17.06%
|
4.90
+10.47%
|
4.43
|
| Research And Development |
|
3.12
+59.10%
|
1.96
+99.59%
|
0.98
+138.76%
|
0.41
|
| Selling General And Administration |
|
4.31
+14.32%
|
3.77
-3.64%
|
3.92
-2.65%
|
4.02
|
| General And Administrative Expense |
|
—
|
—
|
—
|
4.02
|
| Other Gand A |
|
—
|
—
|
—
|
4.02
|
| Total Expenses |
|
8.83
+26.91%
|
6.96
+11.72%
|
6.23
+16.36%
|
5.35
|
| Operating Income |
|
-6.69
-37.31%
|
-4.87
-17.46%
|
-4.15
-5.55%
|
-3.93
|
| Total Operating Income As Reported |
|
-10.28
-111.10%
|
-4.87
-8.87%
|
-4.48
+26.77%
|
-6.11
|
| EBITDA |
|
-10.18
-98.68%
|
-5.12
-23.56%
|
-4.15
+27.78%
|
-5.74
|
| Normalized EBITDA |
|
-6.21
-36.03%
|
-4.57
-19.64%
|
-3.82
-5.71%
|
-3.61
|
| Reconciled Depreciation |
|
0.29
-0.93%
|
0.29
-12.85%
|
0.33
+3.73%
|
0.32
|
| EBIT |
|
-10.46
-93.39%
|
-5.41
-20.88%
|
-4.48
+26.12%
|
-6.06
|
| Total Unusual Items |
|
-3.96
-614.84%
|
-0.55
-69.38%
|
-0.33
+84.62%
|
-2.13
|
| Total Unusual Items Excluding Goodwill |
|
-3.96
-614.84%
|
-0.55
-69.38%
|
-0.33
+84.62%
|
-2.13
|
| Special Income Charges |
|
-3.96
-614.84%
|
-0.55
-69.38%
|
-0.33
+84.62%
|
-2.13
|
| Other Special Charges |
|
0.37
-33.62%
|
0.55
|
—
|
-0.05
|
| Impairment Of Capital Assets |
|
3.60
|
0.00
-100.00%
|
0.33
-84.99%
|
2.18
|
| Net Income |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Pretax Income |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Net Non Operating Interest Income Expense |
|
0.17
+388.75%
|
-0.06
-611.36%
|
-0.01
+93.00%
|
-0.12
|
| Interest Expense Non Operating |
|
0.02
-71.76%
|
0.08
+814.65%
|
0.01
-93.00%
|
0.12
|
| Net Interest Income |
|
0.17
+388.75%
|
-0.06
-611.36%
|
-0.01
+93.00%
|
-0.12
|
| Interest Expense |
|
0.02
-71.76%
|
0.08
+814.65%
|
0.01
-93.00%
|
0.12
|
| Interest Income Non Operating |
|
0.19
+1037.50%
|
0.02
|
0.00
|
—
|
| Interest Income |
|
0.19
+1037.50%
|
0.02
|
0.00
|
—
|
| Other Income Expense |
|
-3.96
-614.84%
|
-0.55
-69.38%
|
-0.33
+84.62%
|
-2.13
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Net Income From Continuing Operation Net Minority Interest |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Net Income From Continuing And Discontinued Operation |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Net Income Continuous Operations |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Normalized Income |
|
-6.52
-32.21%
|
-4.93
-18.64%
|
-4.16
-2.66%
|
-4.05
|
| Net Income Common Stockholders |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+29.65%
|
-6.37
|
| Otherunder Preferred Stock Dividend |
|
—
|
—
|
0.00
-100.00%
|
0.20
|
| Diluted EPS |
|
-0.99
-43.48%
|
-0.69
-30.19%
|
-0.53
+33.75%
|
-0.80
|
| Basic EPS |
|
-0.99
-43.48%
|
-0.69
-30.19%
|
-0.53
+33.75%
|
-0.80
|
| Basic Average Shares |
|
10.61
+33.36%
|
7.95
-5.97%
|
8.46
+6.64%
|
7.93
|
| Diluted Average Shares |
|
10.61
+33.36%
|
7.95
-5.97%
|
8.46
+6.64%
|
7.93
|
| Diluted NI Availto Com Stockholders |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+29.65%
|
-6.37
|
| Line Item | Trend | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Total Assets |
|
7.47
-0.63%
|
7.52
-20.51%
|
9.46
-25.77%
|
12.74
|
| Current Assets |
|
4.79
+369.17%
|
1.02
-62.07%
|
2.69
-50.71%
|
5.47
|
| Cash Cash Equivalents And Short Term Investments |
|
4.31
+774.69%
|
0.49
-75.17%
|
1.99
-59.41%
|
4.89
|
| Cash And Cash Equivalents |
|
4.31
+774.69%
|
0.49
-75.17%
|
1.99
-59.41%
|
4.89
|
| Receivables |
|
0.07
-50.32%
|
0.15
+31.50%
|
0.11
+58.37%
|
0.07
|
| Accounts Receivable |
|
0.07
-50.32%
|
0.15
+31.50%
|
0.11
+58.37%
|
0.07
|
| Inventory |
|
0.21
+25.76%
|
0.17
-26.48%
|
0.23
+74.20%
|
0.13
|
| Raw Materials |
|
0.15
-2.14%
|
0.15
|
—
|
—
|
| Work In Process |
|
0.05
+519.54%
|
0.01
|
—
|
—
|
| Finished Goods |
|
0.02
+90.75%
|
0.01
|
—
|
—
|
| Prepaid Assets |
|
0.20
-7.09%
|
0.21
-42.16%
|
0.37
-1.23%
|
0.37
|
| Total Non Current Assets |
|
2.68
-58.80%
|
6.50
-3.95%
|
6.76
-7.03%
|
7.27
|
| Net PPE |
|
0.70
-13.80%
|
0.81
-16.05%
|
0.96
-3.79%
|
1.00
|
| Gross PPE |
|
1.55
+4.08%
|
1.49
+1.39%
|
1.47
+11.03%
|
1.32
|
| Accumulated Depreciation |
|
-0.85
-25.22%
|
-0.68
-34.42%
|
-0.51
-56.78%
|
-0.32
|
| Machinery Furniture Equipment |
|
1.40
+7.02%
|
1.31
+4.11%
|
1.26
+8.82%
|
1.16
|
| Other Properties |
|
0.14
-17.83%
|
0.18
-15.13%
|
0.21
+26.71%
|
0.16
|
| Goodwill And Other Intangible Assets |
|
1.98
-65.18%
|
5.69
-1.95%
|
5.80
-7.55%
|
6.28
|
| Goodwill |
|
1.72
-65.76%
|
5.02
+0.00%
|
5.02
-6.12%
|
5.35
|
| Other Intangible Assets |
|
0.26
-60.83%
|
0.67
-14.50%
|
0.78
-15.80%
|
0.93
|
| Total Liabilities Net Minority Interest |
|
1.04
-3.51%
|
1.08
+22.13%
|
0.88
+0.34%
|
0.88
|
| Current Liabilities |
|
0.98
-1.63%
|
1.00
+33.46%
|
0.75
-3.93%
|
0.78
|
| Payables And Accrued Expenses |
|
0.70
+2.75%
|
0.68
+27.20%
|
0.53
-16.40%
|
0.64
|
| Current Debt And Capital Lease Obligation |
|
0.13
-20.63%
|
0.16
+216.39%
|
0.05
+52.56%
|
0.03
|
| Current Debt |
|
0.13
+0.76%
|
0.13
+544.29%
|
0.02
+39.81%
|
0.01
|
| Other Current Borrowings |
|
0.13
+0.76%
|
0.13
+544.29%
|
0.02
+39.81%
|
0.01
|
| Current Capital Lease Obligation |
|
0.00
-100.00%
|
0.03
+9.54%
|
0.03
+61.87%
|
0.02
|
| Current Deferred Liabilities |
|
0.16
-1.03%
|
0.16
-3.32%
|
0.16
+53.30%
|
0.11
|
| Current Deferred Revenue |
|
0.16
-1.03%
|
0.16
-3.32%
|
0.16
+53.30%
|
0.11
|
| Total Non Current Liabilities Net Minority Interest |
|
0.06
-27.09%
|
0.08
-40.77%
|
0.13
+33.28%
|
0.10
|
| Long Term Debt And Capital Lease Obligation |
|
0.06
-27.09%
|
0.08
-40.77%
|
0.13
+33.28%
|
0.10
|
| Long Term Debt |
|
0.06
-27.09%
|
0.08
-20.57%
|
0.10
-0.62%
|
0.10
|
| Long Term Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
0.03
|
0.00
|
| Stockholders Equity |
|
6.43
-0.14%
|
6.44
-24.90%
|
8.57
-27.71%
|
11.86
|
| Common Stock Equity |
|
6.43
-0.14%
|
6.44
-24.90%
|
8.57
-27.71%
|
11.86
|
| Capital Stock |
|
0.01
+25.00%
|
0.01
+13.11%
|
0.01
-14.44%
|
0.01
|
| Common Stock |
|
0.01
+25.00%
|
0.01
+13.11%
|
0.01
-14.44%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
11.11
+25.22%
|
8.87
+13.09%
|
7.84
-14.59%
|
9.18
|
| Ordinary Shares Number |
|
11.07
+25.00%
|
8.86
+13.11%
|
7.83
-14.40%
|
9.15
|
| Treasury Shares Number |
|
0.03
+224.00%
|
0.01
+0.00%
|
0.01
-69.52%
|
0.03
|
| Additional Paid In Capital |
|
45.03
+30.74%
|
34.44
+10.77%
|
31.09
+3.76%
|
29.97
|
| Retained Earnings |
|
-38.46
-37.46%
|
-27.98
-24.38%
|
-22.49
-24.89%
|
-18.01
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.00
+0.00%
|
-0.00
+0.00%
|
-0.00
+0.00%
|
-0.00
|
| Treasury Stock |
|
0.15
+355.09%
|
0.03
+0.00%
|
0.03
-68.75%
|
0.10
|
| Other Equity Adjustments |
|
-0.00
+0.00%
|
-0.00
+0.00%
|
-0.00
+0.00%
|
-0.00
|
| Total Equity Gross Minority Interest |
|
6.43
-0.14%
|
6.44
-24.90%
|
8.57
-27.71%
|
11.86
|
| Total Capitalization |
|
6.49
-0.47%
|
6.52
-24.85%
|
8.67
-27.48%
|
11.96
|
| Working Capital |
|
3.81
+16638.78%
|
0.02
-98.83%
|
1.95
-58.49%
|
4.69
|
| Invested Capital |
|
6.62
-0.45%
|
6.65
-23.56%
|
8.69
-27.40%
|
11.97
|
| Total Debt |
|
0.19
-22.77%
|
0.24
+29.86%
|
0.19
+38.07%
|
0.13
|
| Capital Lease Obligations |
|
0.00
-100.00%
|
0.03
-47.72%
|
0.07
+239.19%
|
0.02
|
| Net Tangible Assets |
|
4.45
+493.66%
|
0.75
-72.96%
|
2.77
-50.37%
|
5.58
|
| Tangible Book Value |
|
4.45
+493.66%
|
0.75
-72.96%
|
2.77
-50.37%
|
5.58
|
| Current Notes Payable |
|
—
|
0.00
|
0.00
|
0.00
|
| Line Item | Trend | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.63
-31.16%
|
-3.53
-18.09%
|
-2.99
-6.34%
|
-2.81
|
| Cash Flow From Continuing Operating Activities |
|
-4.63
-31.16%
|
-3.53
-18.09%
|
-2.99
-6.34%
|
-2.81
|
| Net Income From Continuing Operations |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Depreciation Amortization Depletion |
|
0.29
-0.93%
|
0.29
-12.85%
|
0.33
+3.73%
|
0.32
|
| Depreciation |
|
0.17
-1.53%
|
0.17
-4.95%
|
0.18
-42.29%
|
0.32
|
| Amortization Cash Flow |
|
0.11
+0.00%
|
0.11
-22.76%
|
0.15
|
—
|
| Depreciation And Amortization |
|
0.29
-0.93%
|
0.29
-12.85%
|
0.33
+3.73%
|
0.32
|
| Amortization Of Intangibles |
|
0.11
+0.00%
|
0.11
-22.76%
|
0.15
|
—
|
| Other Non Cash Items |
|
0.03
-0.02%
|
0.03
-79.35%
|
0.15
-73.07%
|
0.56
|
| Stock Based Compensation |
|
1.54
+107.66%
|
0.74
+1.44%
|
0.73
-18.46%
|
0.90
|
| Provisionand Write Offof Assets |
|
0.00
-100.00%
|
0.12
|
0.00
|
—
|
| Asset Impairment Charge |
|
3.60
|
0.00
-100.00%
|
0.33
-84.99%
|
2.18
|
| Operating Gains Losses |
|
0.37
-33.62%
|
0.55
+218.59%
|
0.17
+428.18%
|
-0.05
|
| Gain Loss On Investment Securities |
|
—
|
—
|
0.17
|
—
|
| Change In Working Capital |
|
0.03
-84.73%
|
0.22
+201.78%
|
-0.22
+59.49%
|
-0.54
|
| Change In Receivables |
|
0.07
+148.58%
|
-0.15
-269.54%
|
-0.04
-196.97%
|
0.04
|
| Changes In Account Receivables |
|
0.07
+148.58%
|
-0.15
-269.54%
|
-0.04
-196.97%
|
0.04
|
| Change In Inventory |
|
-0.04
-171.52%
|
0.06
+162.17%
|
-0.10
-23.97%
|
-0.08
|
| Change In Prepaid Assets |
|
0.02
-90.27%
|
0.15
+3292.52%
|
0.00
+101.23%
|
-0.37
|
| Change In Payables And Accrued Expense |
|
0.02
-88.13%
|
0.20
+289.67%
|
-0.10
+27.81%
|
-0.15
|
| Change In Other Working Capital |
|
-0.00
+69.97%
|
-0.01
-109.54%
|
0.06
+191.62%
|
0.02
|
| Change In Other Current Liabilities |
|
-0.03
-9.54%
|
-0.03
+13.77%
|
-0.04
-292.97%
|
-0.01
|
| Investing Cash Flow |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Cash Flow From Continuing Investing Activities |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Net PPE Purchase And Sale |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Purchase Of PPE |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Capital Expenditure |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Net Business Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Financing Cash Flow |
|
8.54
+309.12%
|
2.09
+1203.63%
|
0.16
-97.90%
|
7.63
|
| Cash Flow From Continuing Financing Activities |
|
8.54
+309.12%
|
2.09
+1203.63%
|
0.16
-97.90%
|
7.63
|
| Net Issuance Payments Of Debt |
|
0.28
-86.61%
|
2.09
+11826.73%
|
-0.02
+98.91%
|
-1.63
|
| Issuance Of Debt |
|
0.30
-85.76%
|
2.11
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-0.02
-4.58%
|
-0.02
-11.02%
|
-0.02
+98.91%
|
-1.63
|
| Long Term Debt Issuance |
|
0.30
-85.76%
|
2.11
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-0.02
-4.58%
|
-0.02
-11.02%
|
-0.02
+98.91%
|
-1.63
|
| Net Long Term Debt Issuance |
|
0.28
-86.61%
|
2.09
+11826.73%
|
-0.02
+98.91%
|
-1.63
|
| Net Common Stock Issuance |
|
8.26
|
0.00
+100.00%
|
-0.12
-101.88%
|
6.31
|
| Common Stock Payments |
|
-0.15
|
0.00
+100.00%
|
-0.12
-13.92%
|
-0.10
|
| Repurchase Of Capital Stock |
|
-0.15
|
0.00
+100.00%
|
-0.12
-13.92%
|
-0.10
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
-100.00%
|
0.30
-89.91%
|
2.94
|
| Changes In Cash |
|
3.82
+355.86%
|
-1.49
+48.65%
|
-2.91
-161.32%
|
4.74
|
| Effect Of Exchange Rate Changes |
|
—
|
—
|
0.00
|
0.00
|
| Beginning Cash Position |
|
0.49
-75.17%
|
1.99
-59.41%
|
4.89
+3118.48%
|
0.15
|
| End Cash Position |
|
4.31
+774.69%
|
0.49
-75.17%
|
1.99
-59.41%
|
4.89
|
| Free Cash Flow |
|
-4.72
-31.83%
|
-3.58
-16.72%
|
-3.07
-6.08%
|
-2.89
|
| Interest Paid Supplemental Data |
|
0.01
-23.41%
|
0.01
+72.34%
|
0.00
-77.06%
|
0.02
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
8.41
|
0.00
|
0.00
-100.00%
|
6.42
|
| Issuance Of Capital Stock |
|
8.41
|
0.00
|
0.00
-100.00%
|
6.42
|
| Sale Of Business |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-02-13 View
- 8-K2026-02-03 View
- 8-K2025-12-30 View
- 10-Q2025-12-11 View
- 8-K2025-10-28 View
- 10-Q2025-09-09 View
- 8-K2025-09-03 View
- 8-K2025-08-07 View
- 8-K2025-07-16 View
- 10-Q2025-05-30 View
- 10-K2025-04-28 View
- 8-K2025-04-09 View
- 8-K2025-02-13 View
- 8-K2025-02-12 View
- 8-K2025-01-29 View
- 8-K2024-12-30 View
- 10-Q2024-12-04 View
- 42024-12-02 View
- 42024-11-29 View
- 42024-11-29 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|